Vor Biopharma
Shu Wang has held various research positions in prestigious institutions such as Wesleyan University, The Rockefeller University, Boston Children's Hospital, and Q-State Biosciences before joining Vor Bio in August 2019. Shu Wang's educational background includes a Bachelor's degree in Molecular Biology and Biochemistry, as well as Economics from Wesleyan University.
This person is not in the org chart
Vor Biopharma
3 followers
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer. It is focused on developing technologies that can enable selective targeting of cancer cells without impacting normal cells.